Sernova Corp. (OTCMKTS:SEOVF – Get Free Report) was the target of a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 7,400 shares, a drop of 35.1% from the May 31st total of 11,400 shares. Based on an average trading volume of 55,300 shares, the short-interest ratio is currently 0.1 days.
Wall Street Analysts Forecast Growth
Separately, Raymond James started coverage on shares of Sernova in a report on Thursday, April 4th. They set a “market perform” rating and a $1.50 price objective on the stock.
Get Our Latest Stock Analysis on Sernova
Sernova Stock Down 3.0 %
Sernova (OTCMKTS:SEOVF – Get Free Report) last released its earnings results on Friday, June 14th. The company reported ($0.02) earnings per share for the quarter.
About Sernova
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Recommended Stories
- Five stocks we like better than Sernova
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- Health Care Stocks Explained: Why You Might Want to Invest
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- How to Invest in the FAANG Stocks
- MarketBeat Week in Review – 6/24 – 6/28
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.